BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Comba A, Faisal SM, Dunn PJ, Argento AE, Hollon TC, Al-holou WN, Varela ML, Zamler DB, Quass GL, Apostolides PF, Abel C, Brown CE, Kish PE, Kahana A, Kleer CG, Motsch S, Castro MG, Lowenstein PR. Spatiotemporal analysis of glioma heterogeneity reveals Col1A1 as an actionable target to disrupt tumor mesenchymal differentiation, invasion and malignancy.. [DOI: 10.1101/2020.12.01.404970] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Franson A, McClellan BL, Varela ML, Comba A, Syed MF, Banerjee K, Zhu Z, Gonzalez N, Candolfi M, Lowenstein P, Castro MG. Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment. Front Med (Lausanne) 2022;9:966458. [PMID: 36186781 DOI: 10.3389/fmed.2022.966458] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]